Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Briacell Therapeutics Corp

BCT
Current price
0.97 CAD 0 CAD (0.00%)
Last closed 0.97 CAD
ISIN CA10778Y3023
Sector Healthcare
Industry Biotechnology
Exchange Toronto Exchange
Capitalization 39 832 763 CAD
Yield for 12 month -82.49 %
1Y
3Y
5Y
10Y
15Y
BCT
21.11.2021 - 28.11.2021

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. BriaCell Therapeutics Corp. is based in West Vancouver, Canada. Address: Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

27.82 CAD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-20 507 CAD

Last Year

-19 401 CAD

Current Quarter

-5 184 CAD

Last Quarter

-5 167 CAD

Key Figures BCT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -33 272 277 CAD
Operating Margin TTM
PE Ratio
Return On Assets TTM -126.11 %
PEG Ratio
Return On Equity TTM -206.01 %
Wall Street Target Price 27.82 CAD
Revenue TTM
Book Value -0.13 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.4 CAD
Diluted Eps TTM -0.4 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BCT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BCT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1009:1000
Payout Ratio
Last Split Date 05.09.2023
Dividend Date 02.01.2020

Stock Valuation BCT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.8746
Price Book MRQ 16.9685

Financials BCT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BCT

For 52 weeks

0.64 CAD 8.01 CAD
50 Day MA 1.09 CAD
Shares Short Prior Month 1 892
200 Day MA 2.44 CAD
Short Ratio 0.06
Shares Short 6 075
Short Percent 0.02 %